Recruiting at 1 site No phase Relapse/Recurrence

Prevention trial for Relapse/Recurrence

Official title Mindfulness-based Relapse Prevention for Peer Workers

ClinicalTrials.gov ID: NCT07741825

What this study is testing

What it's testing
The study wants to find out whether a mindfulness‑based relapse prevention program can reduce substance use, relapse risk, and burnout among people who work as peer supporters for substance use.
Who it's for
Peer workers who provide support to people with substance use problems and who have their own history of drug or alcohol use.
What's involved
Participants will join eight weekly 2‑hour virtual mindfulness sessions, complete four online surveys about their well‑being, and take part in one virtual interview about their experience.
Time commitment
The trial lasts about two months, with weekly online sessions and a few short surveys and one interview.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 100

You may be able to join if

  • Are \> 18 years old
  • Fluent in English
  • Be currently employed in a substance use peer support role
  • At-risk for SUD relapse as measured by a craving score of \>15 on the adapted Penn Alcohol Craving Scale

You likely can't join if

  • Have a cognitive impairment that jeopardizes informed consent
  • Actively suicidal or psychotic

The study team makes the final eligibility decision.

Where it is enrolling

  • Austin, Texas, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Austin, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.